Comparing Chemotherapy Drugs for Medulloblastoma
Author Information
Author(s): F.H. Tomlinson, M.G. Lihoul, P.J. Smith
Primary Institution: Queensland Institute of Medical Research
Hypothesis
The study investigates the sensitivity of medulloblastoma tumors to various chemotherapy agents, particularly epipodophyllotoxins.
Conclusion
The epipodophyllotoxin VM-26 showed the highest sensitivity in medulloblastoma cultures, suggesting its potential as a key treatment option.
Supporting Evidence
- Nine out of ten tumors tested were sensitive to mafosfamide.
- Twelve of thirteen tumors were sensitive to teniposide.
- Seven out of thirteen tumors were sensitive to etoposide.
- Three early passage cultures were more resistant to epipodophyllotoxins than average.
Takeaway
Doctors tested different cancer drugs on brain tumors from kids to see which ones worked best, and found that one drug, VM-26, worked really well.
Methodology
The study used early passage cultures from surgical specimens of medulloblastoma patients to assess drug sensitivity using the 3H-thymidine uptake method.
Limitations
The study's findings may not fully represent the in vivo response due to the limited sample size and the nature of early passage cultures.
Participant Demographics
Patients ranged from 3 to 11 years old, with a male to female ratio of 2:1.
Statistical Information
P-Value
p<0.002
Statistical Significance
p<0.002
Want to read the original?
Access the complete publication on the publisher's website